Key result
Soy isoflavones lower total cholesterol by ~0.12 mmol/L in postmenopausal women.
Why the study?
This study aimed to evaluate the impact of soy protein containing isoflavones and soy isoflavones extract on the plasma lipid profile in postmenopausal women as a potential prevention factor in cardiovascular diseases.
Does supplementation with soy protein containing isoflavones or soy isoflavones extract improve the plasma lipid profile compared with placebo or control proteins in postmenopausal women?
Meta-Analysis (n=2,305)
Double-blind
Randomized parallel-group controlled trials
Yes
Does supplementation with soy protein containing isoflavones or soy isoflavones extract improve the plasma lipid profile compared with placebo or control proteins in postmenopausal women?
Answers are grounded in this paper and cite their sources.
This meta-analysis of 29 RCTs demonstrates that soy protein containing isoflavones and isoflavone extracts modestly but significantly lower total cholesterol and raise HDL-C in postmenopausal women, supporting soy intake as a dietary adjunct for cardiovascular risk reduction.
The aim of the report was to evaluate the impact of soy protein containing isoflavones and soy isoflavones extract on lipid profile in postmenopausal women, as compared with placebo or protein of milk, casein or isolated soy protein with or without trace isoflavone content. We used the following databases: MEDLINE (PubMed), EMBASE and the Cochrane Library. Quantitative data synthesis was performed by applying a random-effects model. Subgroup analysis and meta-regression were performed to assess the modifiers of treatment response. In total, in the analysis studies, 2305 postmenopausal women took part. Changes in the lipid profile showed statistically significant decreases of total cholesterol by −0.12 (95% CI: −0.21, −0.03) mmol/L, −4.64 (95% CI: −8.12, −1.16) mg/dL, p = 0.01 and increased HDL-cholesterol by 0.03 (95% CI: 0.00, 0.06) mmol/L, 1.15 (95% CI: 0.00, 1.93) mg/dL, p = 0.05, as well as in LDL-cholesterol −0.05 (95% CI: −0.11, 0.01) mmol/L, −1.93 (95% CI: −4.25, 0.39) mg/dL, p = 0.08 and triacylglycerols −0.07 (95% CI: −0.14, 0.00) mmol/L, −6.123 (95% CI: −12.25, 0.00) mg/dL, p = 0.06. Our results suggests that soy and its isoflavones can be effective in correction changes in lipid metabolism in postmenopausal women and may favorably influence in preventing cardiovascular events.
No takes yet. Share an insight, caveat, or question.
Barańska et al. (2021) conducted a meta-analysis in Postmenopausal lipid metabolism / cardiovascular disease prevention (n=2,305). Soy protein containing isoflavones or soy isoflavones extract vs. Placebo, milk protein, casein, or isolated soy protein with or without trace isoflavone content was evaluated on Net change in serum total cholesterol (mmol/L) (MD -0.12 mmol/L (-4.64 mg/dL), 95% CI -0.21 to -0.03, p=0.007). Soy protein with isoflavones and isoflavone extracts reduced total cholesterol by 0.12 mmol/L and increased HDL-C by 0.03 mmol/L in postmenopausal women.
Synapse has enriched 10 related papers. Consider them for comparative context: